Changing family behavior helps schizophrenic patients avoid relapse

Nov 10, 2010

Working to change the behaviour of family members may be an effective treatment for people with schizophrenia, according to a new Cochrane systematic review. The researchers reviewed the most up-to-date evidence on the subject and found that patients whose families received the interventions were less likely to relapse.

It has long been known that people who have are more likely to relapse if they come from families where they experience high levels of criticism, hostility and over involvement. New psychosocial interventions that aim to reduce levels of these potentially are now widely used, although their effectiveness has not been proved.

The researchers reviewed data from 53 trials involving a total of 4,708 . Interventions lasted from six weeks to three years and involved a range of psychosocial techniques aimed at reducing stress and levels of expressed emotions, and helping family members to solve patient problems. Patients in control groups were given standard care, including their usual drug treatments. Patients were assessed using a wide variety of different scales for general and , social functioning, behaviour and quality of life.

The main benefit of family interventions was a decrease in relapses. Results from 32 of the trials showed that for every seven patients whose relatives were given family interventions, one benefited compared to control groups. Family interventions also significantly reduced hospital admissions over a year, improved patients' social functioning and encouraged them to stick to drug treatment regimes.

"Prevention of relapse is a cornerstone of psychiatric care," said lead researcher Fiona Pharoah of Oxford and Buckinghamshire Mental Health NHS Foundation Trust, UK. "If high quality family services are available, mental health professionals and managers may feel that family interventions are a worthwhile investment of time and effort for schizophrenic patients." However, the numbers of patients that would need to be treated in order to see a benefit may deter policy makers from investing in family interventions.

Explore further: Recorded Ebola deaths top 7,000

add to favorites email to friend print save as pdf

Related Stories

Can Family Therapy Help The Depressed Patient?

Apr 07, 2009

A study published in the current issue of Psychotherapy and Psychosomatics suggests that single-family and multi-family therapy may benefit hospitalized patients with major depression, and may help the partners of the patients ...

Acamprosate prevents relapse to drinking in alcoholism

Sep 08, 2010

Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in addition to non-drug treatm ...

Recommended for you

Recorded Ebola deaths top 7,000

20 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.